Science & Technology
(U03)
990 on File
SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS
Financial strength (30%)
72/100
Reliability (20%)
55/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$263K
Total Revenue
$227K
Total Expenses
$422K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
96.4%
Fundraising Efficiency
N/A
Operating Reserve
22.31x
Liability-to-Asset
0.0%
Revenue Diversification
78.3%
Compared with Peers
FY 2024
Compared with 515 similar organizations
(United States, Science & Technology, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
96.4% | 84.9% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
3.6% | 13.3% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
22.3 mo | 11.4 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.8% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
78.3% | 91.9% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
40.6% | 9.3% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
31.5% | 10.0% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
13.5% | 4.7% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $263K | $227K | $422K | 96.4% | 0 |
| 2023 | $187K | $173K | $387K | 99.0% | — |
| 2022 | $144K | $95K | $373K | 99.1% | — |
| 2021 | $71K | $16K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.